comparemela.com

Page 17 - Oxurion News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Oxurion NV: Information on the Total Number of Voting Rights (Denominator) following EUR > 10 million Private Placement and conversion notice from NEGMA

Oxurion has successfully raised EUR >10 million from leading US and European healthcare investors in a private equity placement and Negma Group has converted 240 convertible bonds in Oxurion resulting

United statesRegion flamandeTom graneySylvie berrebi frazer hallChristopher brinzeyCompany annualNegma group onNegma groupKreos capital vi united kingdomCompany or oxurionBelgian actEuronext brusselsCapital commitmentKreos capitalUnited kingdomPontifax medison finance

Oxurion NV: Oxurion Receives Transparency Notifications from Fidelity Management & Research Company LLC and Novartis Pharma AG

Leuven, Belgium, Boston, MA, US - March 17, 2022 - 07.00 PM CET - Oxurion NV(Euronext Brussels: OXUR) (the "Company" or "Oxurion"), a biopharmaceutical company developing next generation

United statesRegion flamandeTom graneySylvie berrebi frazer hallChristopher brinzeyFidelity management research companyCompany or oxurionEuronext brusselsFidelity managementResearch companyNovartis pharmaNovartis notificationTransparency notification

Americans for Ben-Gurion University to Raise Emergency Funds for Ukrainian Students

Donations will support Ben-Gurion University of the Negev's initiative to welcome impacted students to its campusesNEW YORK, NY / ACCESSWIRE / March 10, 2022 / Americans for Ben-Gurion University (A4BGU)

United statesBrian sherryKostenloser wertpapierhandelDavid ben gurionDoug sesermanStern strategy groupBen gurion university of the negevBen gurion university

Oxurion NV: Oxurion Successfully Closes EUR >10 Million in Private Placement

Led by new top-tier healthcare institutional investors along with participation by current major shareholders Leuven, BELGIUM, Boston, MA, US - MARCH 7, 2022 - 10.00 AM CET - Oxurion

United statesRegion flamandeTom graneySylvie berrebi frazer hallChristopher brinzeyCompany annualCompany or oxurionEuronext brusselsPrivate placement

Oxurion NV: OXURION SUCCESSFULLY RAISES EUR >10 MILLION FROM LEADING US AND EUROPEAN HEALTHCARE INVESTORS IN A PRIVATE EQUITY PLACEMENT

Leuven, BELGIUM, Boston, MA, US - MARCH 3, 2022 - 08:00 AM CET - Oxurion NV (Euronext Brussels: OXUR) (the "Company" or "Oxurion"), a biopharmaceutical company developing next generation

United statesRegion flamandeUnited kingdomTom graneyBaron philippe vlerickSylvie berrebi frazer hallThomas clayChristopher brinzeyBelgian code on companiesCouncil of the european unionCompany annualEuropean parliamentBank degroof petercam sa nv degroofpetercamFinancial servicesSwiss financial services act finanzdienstleistungsgesetzBelfius bank

vimarsana © 2020. All Rights Reserved.